US Stock MarketDetailed Quotes

ATRA Atara Biotherapeutics

Watchlist
  • 7.333
  • +0.403+5.81%
Trading Jan 24 10:39 ET
42.23MMarket Cap-0.29P/E (TTM)

Atara Biotherapeutics Key Stats

Atara Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 5.067M--
--2024/Q4-- / 17.065M--
Nov 12, 20242024/Q340.190M / 35.168M--
--2024/Q228.640M / 37.092M--
--2024/Q127.357M / 24.690M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 5.067M--
--2024/Q4-- / 17.065M--
Nov 12, 20242024/Q340.190M / 35.168M--
--2024/Q228.640M / 37.092M--
--2024/Q127.357M / 24.690M--

Unlock Free Earnings Estimates

Atara Biotherapeutics Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Jan 24, 2025

Buy

  • Buy

    33.33%
  • Hold

    66.67%
  • Sell

    0.00%

Price Target

No Data